InvestorsHub Logo
Followers 65
Posts 40186
Boards Moderated 2
Alias Born 07/08/2002

Re: growacet post# 964

Thursday, 05/19/2016 12:14:04 AM

Thursday, May 19, 2016 12:14:04 AM

Post# of 1228
Yes. It's from his blog. The link is in this message which is from Feb. There are newer ones, but this is the one I had handy.

See the blog below just out today from Charles Peacock, the first patient in this ZIOP Glioma Trial of VERY sick patients (Ad-RTS-hIL-12, an Inducible Adenoviral Vector Engineered to Express hIL-12 in the Presence of the Activator Ligand Veledimex in Subjects With Recurrent or Progressive Glioblastoma or Grade III Malignant Glioma)

To even be in this trial you must have RECURRENT or PROGESSIVE Glioblastoma or Grade III/IV Malignant Glioma and must have FAILED previous standard of care anti-tumor treatments including surgery and/or biopsy and chemoradiation (Histologically confirmed supratentorial glioblastoma or other WHO grade III or IV malignant glioma from archival tissue)

Dr Cooper said usually these very sick refractory patients would progress in weeks and die in a few months. All of the patients are now six months since initiating the ZIOP treatment and they are all alive. This is indeed important. FDA will now allow dose escalation and a second cohort. Dr Cooper is extremely encouraged by these results. God Speed to Charles Peacock – what an inspiration.
____________________________________________________________________________
click blue link below to get to his website

There’s No Such Thing As Giving Up
POSTED ON FEBRUARY 3, 2016 BY THEBRAINCHANCERY

https://thebrainchancery.com/about/

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TCRT News